跳至主要内容
临床试验/NCT06611020
NCT06611020进行中(未招募)不适用

The Role of Adjuvant VaccInation After Conization for the Treatment for Cervical Dysplasia

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
600
试验地点
1
主要终点
HPV recurrence

研究概览

简要总结

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

详细描述

Patients treated for HPV-related disease are counseled about the potential protective role of HPV vaccination. The investigators will monitor the risk of HPV recurrence in pateints who choce to have vaccination and who did not.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Treatment of HPV-related disease

排除标准

  • Previous HPV vaccination

结局指标

主要结局

HPV recurrence

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
申办方类型
Other
责任方
Principal Investigator
主要研究者

Valentina Chiappa

md

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

研究点 (1)

Loading locations...

相似试验